Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
Medicare would cover CAR-T cell therapies under new CMS proposal
Marketwatch
Fri, 02/15/19 - 12:22 pm
Medicare
CAR-T
cell therapy
CMS
Novartis
Kymriah
Gilead Sciences
Yescarta
Oncology round-up: CAR-T conference raises hopes for solid tumour therapy
Pharmaforum
Fri, 02/1/19 - 10:44 pm
CAR-T
CAR-T Congress
oncology
Novartis
Kymriah
Europe
Novartis changes NICE's mind on Kymriah, giving CAR-T rival Gilead some company
Fierce Pharma
Fri, 02/1/19 - 12:00 am
Novartis
Kymriah
CAR-T
UK
diffuse large B-cell lymphoma
Gilead Sciences
Brexit could hinder CAR-T reimbursement in Europe
Pharmaforum
Thu, 01/31/19 - 11:38 am
Brexit
UK
Europe
CAR-T
Where Will bluebird bio Be in 5 Years?
Motley Fool
Thu, 01/24/19 - 11:41 am
Bluebird Bio
LentiGlobin
bb21217
CAR-T
3 Things You Need to Know About the FDA's Plan for Gene-Editing Drugs
Motley Fool
Sun, 01/20/19 - 10:24 pm
FDA
gene editing
Novartis
Sarepta Therapeutics
CAR-T
Alzheimer's disease
Celgene strikes Obsidian deal to boost CAR-T options
Fierce Biotech
Fri, 01/18/19 - 11:18 am
Celgene
Obsidian Therapeutics
CAR-T
Lilly eyes more cancer deals, but wary of CAR-T, gene therapy
Yahoo/Reuters
Sat, 01/12/19 - 08:49 pm
Eli Lilly
Loxo Oncology
M&A
CAR-T
gene therapy
Novartis building out cell and gene therapy platform that'll lead the pack, CEO promises
Fierce Pharma
Tue, 01/8/19 - 12:38 am
Novartis
Pharma CEOs
CAR-T
Kymriah
Vas Narasimhan
JPMHC 2019
Poseida pitches a $115M IPO on its claim that the science team has created a better BCMA CAR-T
Endpoints
Sun, 01/6/19 - 01:58 pm
Poseida Therapeutics
IPOs
BCMA
CAR-T
Poseida Therapeutics Prepares for IPO to Advance CAR-T Treatments
Xconomy
Sat, 01/5/19 - 12:11 am
Poseida Therapeutics
CAR-T
IPOs
solid tumors
For CAR-T Cancer Fighters in the Real World, Two Roads Diverge
Xconomy
Thu, 01/3/19 - 04:16 pm
cancer
CAR-T
Gilead Sciences
Yescarta
Novartis
Kymriah
TCR2 Shoots for $100 Million IPO in Early 2019
BioSpace
Wed, 01/2/19 - 11:41 am
TCR2 Therapeutics
IPOs
CAR-T
Novartis seeks to acquire French CAR-T contract manufacturer
Biopharma Dive
Thu, 12/20/18 - 11:43 pm
Novartis
M&A
France
CellforCure
CMO
Kymriah
CAR-T
Merck KGaA hands off its CAR-T R&D operations to Intrexon in $175M deal
Endpoints
Thu, 12/20/18 - 11:50 am
Merck KGaA
CAR-T
Intrexion
M&A
Novartis, still struggling with Kymriah manufacturing, is providing some out-of-spec doses to patients who ask
Fierce Pharma
Tue, 12/18/18 - 12:51 pm
Novartis
patients
CAR-T
Kymriah
drug manufacturing
Hospital docs weigh in on CAR-T reimbursement: 'It's very complicated'
BioSpace
Wed, 12/5/18 - 07:42 pm
CAR-T
hospitals
reimbursement
Weekend ASH presentations hint at future of BCMA CARs
BioCentury
Tue, 12/4/18 - 09:39 am
ASH 2018
BCMA
CAR-T
Multiple Myeloma
ASH18: Legend's CAR-T brought back to reality
Biopharma Dive
Mon, 12/3/18 - 10:53 pm
Legend Biotech
ASH 2018
CAR-T
Multiple Myeloma
#ASH18: Allogene ticks off a high CR rate for updated off-the-shelf CAR-T pioneer. But getting just the right kind of immunosuppression is crucial
Endpoints
Mon, 12/3/18 - 10:50 pm
ASH 2018
Allogene
CAR-T
ALL
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »